Status | Study |
Active, not recruiting |
Study Name: Follistatin Gene Transfer to Patients With Becker Muscular Dystrophy and Sporadic Inclusion Body Myositis Condition: Becker Muscular Dystrophy Sporadic Inclusion Body Myositis Date: 2012-01-23 Interventions: Biological: rAAV1.CMV.huFollistatin344 |
Active, not recruiting |
Study Name: Diagnostic Accuracy of Whole Body Magnetic Resonance Imaging in Inflammatory Myopathies Condition: Myositis Polymyositis Dermatomyositis Date: 2011-08-22 Interventions: Procedure: MRI-oriented muscle biopsy Orientation of muscle biopsy according to the MRI results |
Completed |
Study Name: Efficacy, Safety and Tolerability of BYM338 in Patients With Sporadic Inclusion Body Myositis Condition: Sporadic Inclusion Body Myositis Date: 2011-08-12 Interventions: Biological: BYM338 Biological: Placebo |
Recruiting |
Study Name: Investigating Genes in Patients With Polymyositis and Dermatomyositis Condition: Myositis Date: 2010-07-27 Interventions: Procedure: Venepuncture Venepuncture - Taking blood |
Completed |
Study Name: Anakinra in Myositis Condition: Polymyositis Dermatomyositis Inclusi Date: 2010-07-16 Interventions: Drug: Anakinra |
Completed |
Study Name: Lithium in Inclusion Body Myositis (IBM) Condition: Inclusion Body Myositis Date: 2009-06-08 |
Completed |
Study Name: Muscle Strength and Inflammatory Response in Patients With Inclusion Body Myositis Condition: Inclusion Body Myositis Date: 2009-05-11 |
Completed |
Study Name: Double-blind, Randomized, Placebo-controlled Trial of Etanercept for 12 Months in Subjects With Inclusion Body Myositis Condition: Inclusion Body Myositis Date: 2008-12-04 Interventions: Drug: Etanercept 50 milligrams subcutaneously every week |
Completed |
Study Name: Arimoclomol in Sporadic Inclusion Body Myositis Condition: Inclusion Body Myositis Date: 2008-10-08 Interventions: Drug: Arimoclomol Arimoclomol |
Completed |
Study Name: Treatment With TNF Blockade, Infliximab, in Patients With Myositis Condition: Refractory Myositis Date: 2007-03-02 Interventions: Drug: Infliximab |